Generally, the power of attorney is expected to be used with great caution and only in exceptional circumstances because its grants extensive authority to an agent.
<h3>What is power of attorney?</h3>
This power is inferred in a a written document that confers express authority to agent and is usually notarized.
Hence, it is expected to be used with great caution and only in exceptional circumstances because its grants extensive authority to an agent.
Therefore, the Option B is correct.
Read more about power of attorney
<em>brainly.com/question/20397360</em>
You may distribute business cards to individuals who request information on how to contact you for further details on the plan(s) you represent.
<h3>What are LCD and NCD guidelines?</h3>
While a contractor or economic intermediary makes a ruling as to whether a provider or item may be reimbursed, it is referred to as a nearby insurance determination (liquid crystal display). while CMS makes a desire in response to a right away request as to whether or not or no longer service or object can be covered, it is known as national insurance willpower (NCD).
An LCD is a choice with the aid of a Medicare contractor whether or not to cowl a selected object or provider. LCDs include “reasonable and vital” statistics and are administrative and academic gear to help you in submitting accurate claims for a fee.
Learn more about Medicare’s guidance here brainly.com/question/27758489
#SPJ10
Answer:
Friction can increase gravity on a surface
Explanation:
This applies because of the increase in gravity
Possible Answer
B.
<em>Not 100% on this on but pretty sur it is B.</em>
Hope this helps :)
Answer:
The Drug Quality and Security Act (DQSA), was enacted by Congress on November 27, 2013. Title II of DQSA, the Drug Supply Chain Security Act (DSCSA), outlines steps to achieve interoperable, electronic tracing of products at the package level to identify and trace certain prescription drugs as they are distributed in the United States. This will enhance FDA’s ability to help protect consumers from exposure to drugs that may be counterfeit, stolen, contaminated, or otherwise harmful. These requirements will also improve detection and removal of potentially dangerous drugs from the drug supply chain to protect U.S. consumers.
Additionally, the DSCSA directs FDA to establish national licensure standards for wholesale distributors and third-party logistics providers, and requires these entities report licensure and other information to FDA annually.
Explanation:
